Ifosfamide-pharmacology, safety and therapeutic potential-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ifosfamide-pharmacology, safety and therapeutic potential

Published:1985-03 Issue:1 Volume:12 Page:1-47
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Brade W.P.,Herdrich K.,Varini M.

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Reference291 articles.

1. Toxicological investigations of Ifosfamide;Abel,1977

2. A phase II evaluation of Ifosfamide (NSC 109 724) treatment of disseminated breast cancer;Ahmann,1974

3. Therapy in far advanced testicular cancer;Aiginger;Blut,1982

4. Ifosfamide and Cisplatinum in testicular tumour patients resistant to vinblastine-bleomycin-cisplatinum;Aiginger,1982

5. In vitro activation of isophosphamide (NSC-109724), a new oxazaphosphorine, by rat liver microsomes;Allen;Cancer Chemother. Rep,1972

Cited by 238 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unravelling biochemical responses in the species Mytilus galloprovincialis exposed to the antineoplastics ifosfamide and cisplatin under different temperature scenarios;Science of The Total Environment;2024-09

2. Evaluation of Nephroprotective effect of Ubiquinol on Ifosfamide Induced Nephrotoxicity in Albino Wistar Rats;Research Journal of Pharmacy and Technology;2024-05-15

3. Drug-Related Cystitis: An Overview;Cystitis - Updates and Challenges;2023-10-11

4. Chapter 1: Evaluation of kidney function in patients undergoing anticancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022;International Journal of Clinical Oncology;2023-06-29

5. Population pharmacokinetic analysis reveals no impact of aprepitant on the pharmacokinetics of ifosfamide, 2-dechloroifosfamide, and 3-dechloroifosfamide;European Journal of Pharmaceutical Sciences;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3